Ignite Creation Date:
2025-12-26 @ 10:56 AM
Ignite Modification Date:
2026-01-01 @ 6:32 AM
Study NCT ID:
NCT05202808
Status:
COMPLETED
Last Update Posted:
2025-04-20
First Post:
2021-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
Sponsor:
RxSight, Inc.
Organization:
Study Overview
Official Title:
RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
Status:
COMPLETED
Status Verified Date:
2025-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to conduct a post-approval study which compares the LAL to a monofocal control IOL for safety outcomes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: